TrialGynecologic oncology2011

Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.

S John Weroha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.